Stockreport

Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026

Calidi Biotherapeutics, Inc.  (CLDI) 
PDF Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver hig [Read more]